Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 17050781)

1.

Identification and functional analysis of common human flavin-containing monooxygenase 3 genetic variants.

Koukouritaki SB, Poch MT, Henderson MC, Siddens LK, Krueger SK, VanDyke JE, Williams DE, Pajewski NM, Wang T, Hines RN.

J Pharmacol Exp Ther. 2007 Jan;320(1):266-73. Epub 2006 Oct 18.

2.

Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variants.

Koukouritaki SB, Poch MT, Cabacungan ET, McCarver DG, Hines RN.

Mol Pharmacol. 2005 Aug;68(2):383-92. Epub 2005 Apr 27.

3.

Haplotype frequency distribution and linkage disequilibrium analysis of single nucleotide polymorphisms at the human FMO3 gene locus.

Hao DC, Sun J, Furnes B, Schlenk D, Hou ZF, Zhang YP, Yang SL, Yang L.

Biochem Genet. 2006 Oct;44(7-8):391-407. Epub 2006 Nov 10.

PMID:
17096187
4.

Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics.

Krueger SK, Siddens LK, Henderson MC, Andreasen EA, Tanguay RL, Pereira CB, Cabacungan ET, Hines RN, Ardlie KG, Williams DE.

Pharmacogenet Genomics. 2005 Apr;15(4):245-56.

5.

Two new polymorphisms of the FMO3 gene in Caucasian and African-American populations: comparative genetic and functional studies.

Lattard V, Zhang J, Tran Q, Furnes B, Schlenk D, Cashman JR.

Drug Metab Dispos. 2003 Jul;31(7):854-60. Erratum in: Drug Metab Dispos. 2004 Feb;32(2):280.

6.

Flavin-containing monooxygenase 3 gene polymorphisms in Turkish population.

Ozhan G, Topal P, Alpertunga B.

Toxicol Mech Methods. 2012 Jul;22(6):461-5. doi: 10.3109/15376516.2012.672481.

PMID:
22409263
7.

Population distribution of human flavin-containing monooxygenase form 3: gene polymorphisms.

Cashman JR, Zhang J, Leushner J, Braun A.

Drug Metab Dispos. 2001 Dec;29(12):1629-37.

8.

FMO3 allelic variants in Sicilian and Sardinian populations: trimethylaminuria and absence of fish-like body odor.

D'Angelo R, Esposito T, Calabrò M, Rinaldi C, Robledo R, Varriale B, Sidoti A.

Gene. 2013 Feb 25;515(2):410-5. doi: 10.1016/j.gene.2012.12.047. Epub 2012 Dec 21.

PMID:
23266626
9.

Allele and genotype frequencies of polymorphic FMO3 gene in two genetically distinct populations.

Hao D, Sun J, Furnes B, Schlenk D, Li M, Yang S, Yang L.

Cell Biochem Funct. 2007 Jul-Aug;25(4):443-53.

PMID:
16598836
10.
11.

Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria.

Motika MS, Zhang J, Zheng X, Riedler K, Cashman JR.

Mol Genet Metab. 2009 Jun;97(2):128-35. doi: 10.1016/j.ymgme.2009.02.006. Epub 2009 Feb 27.

12.

Flavin-containing monooxygenase 3 polymorphisms in 13 ethnic populations from Europe, East Asia and sub-Saharan Africa: frequency and linkage analysis.

Mao M, Matimba A, Scordo MG, Gunes A, Zengil H, Yasui-Furukori N, Masimirembwa C, Dahl ML.

Pharmacogenomics. 2009 Sep;10(9):1447-55. doi: 10.2217/pgs.09.77.

PMID:
19761368
13.

Genetic variability at the human FMO1 locus: significance of a basal promoter yin yang 1 element polymorphism (FMO1*6).

Hines RN, Luo Z, Hopp KA, Cabacungan ET, Koukouritaki SB, McCarver DG.

J Pharmacol Exp Ther. 2003 Sep;306(3):1210-8. Epub 2003 Jun 26.

14.

Flavin monooxygenase 3 (FMO3) polymorphism in a white population: allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism.

Sachse C, Ruschen S, Dettling M, Schley J, Bauer S, Müller-Oerlinghausen B, Roots I, Brockmöller J.

Clin Pharmacol Ther. 1999 Oct;66(4):431-8.

PMID:
10546928
15.

Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria.

Yeung CK, Adman ET, Rettie AE.

Arch Biochem Biophys. 2007 Aug 15;464(2):251-9. Epub 2007 May 2.

16.

Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans.

Furnes B, Feng J, Sommer SS, Schlenk D.

Drug Metab Dispos. 2003 Feb;31(2):187-93.

17.

Patterns of association between PPARgamma genetic variation and indices of adiposity and insulin action in African-Americans and whites: the CARDIA Study.

Wei Q, Jacobs DR Jr, Schreiner PJ, Siscovick DS, Steffes MW, Fornage M.

J Mol Med (Berl). 2006 Nov;84(11):955-65. Epub 2006 Sep 6.

PMID:
16955276
18.
19.

Effects upon in-vivo nicotine metabolism reveal functional variation in FMO3 associated with cigarette consumption.

Bloom AJ, Murphy SE, Martinez M, von Weymarn LB, Bierut LJ, Goate A.

Pharmacogenet Genomics. 2013 Feb;23(2):62-8. doi: 10.1097/FPC.0b013e32835c3b48.

PMID:
23211429
20.

Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption.

Chenoweth MJ, Zhu AZ, Sanderson Cox L, Ahluwalia JS, Benowitz NL, Tyndale RF.

Pharmacogenet Genomics. 2014 Mar;24(3):172-6. doi: 10.1097/FPC.0000000000000031.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk